Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12405

Related search